We are live on ! Find out more
CCM

Chiron Capital Management Portfolio holdings

AUM $111M
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$137M
AUM Growth
+$17.1M
Cap. Flow
+$25.1M
Cap. Flow %
18.33%
Top 10 Hldgs %
53.07%
Holding
103
New
24
Increased
39
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.99M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.29M
3
T icon
AT&T
T
+$3.04M
4
LMT icon
Lockheed Martin
LMT
+$1.56M
5
UBER icon
Uber
UBER
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 43.41%
2 Technology 9.71%
3 Energy 6.58%
4 Communication Services 6.2%
5 Consumer Staples 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$127B
$42.3M 30.82%
714,086
+50,004
+8% +$3.29M
GILD icon
2
Gilead Sciences
GILD
$161B
$6.62M 4.83%
94,742
-24,464
-21% -$1.72M
T icon
3
AT&T
T
$165B
$5.78M 4.21%
283,141
+144,588
+104% +$3.04M
XBI icon
4
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$4.97M 3.62%
39,526
+31,015
+364% +$3.99M
PFE icon
5
Pfizer
PFE
$140B
$2.78M 2.03%
64,571
-69,938
-52% -$3.1M
INTC icon
6
Intel
INTC
$466B
$2.52M 1.84%
47,319
+15,205
+47% +$824K
CTXS
7
DELISTED
Citrix Systems Inc
CTXS
$2.08M 1.52%
19,400
+300
+2% +$32.4K
FTSM icon
8
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
$2M 1.46%
33,441
-718
-2% -$43K
BUD icon
9
AB InBev
BUD
$158B
$1.9M 1.39%
33,695
+11,635
+53% +$730K
XOM icon
10
ExxonMobil
XOM
$651B
$1.87M 1.36%
31,744
+19,015
+149% +$1.08M
AFGR
11
First Trust Active Factor Large Cap Growth ETF
AFGR
$90.5M
$1.77M 1.29%
65,178
+261
+0.4% +$7.19K
MRK icon
12
Merck
MRK
$324B
$1.76M 1.29%
23,500
+2,650
+13% +$202K
EPD icon
13
Enterprise Products Partners
EPD
$83.8B
$1.75M 1.27%
80,747
+26,222
+48% +$596K
SHW icon
14
Sherwin-Williams
SHW
$78.3B
$1.71M 1.24%
6,100
-142
-2% -$41.6K
GLD icon
15
SPDR Gold Trust
GLD
$131B
$1.63M 1.19%
9,900
+4,300
+77% +$720K
HD icon
16
Home Depot
HD
$332B
$1.62M 1.18%
4,933
-152
-3% -$49.9K
FMB icon
17
First Trust Managed Municipal ETF
FMB
$2.03B
$1.59M 1.16%
28,021
-1,192
-4% -$68.5K
SLB icon
18
SLB Ltd
SLB
$77.8B
$1.51M 1.1%
50,850
+11,620
+30% +$333K
UBER icon
19
Uber
UBER
$134B
$1.5M 1.09%
+33,430
New +$1.46M
LMT icon
20
Lockheed Martin
LMT
$134B
$1.49M 1.08%
+4,310
New +$1.56M
AMZN icon
21
Amazon
AMZN
$2.5T
$1.48M 1.08%
9,020
VMW
22
DELISTED
VMware, Inc
VMW
$1.43M 1.04%
+9,600
New +$1.46M
AAPL icon
23
Apple
AAPL
$4.89T
$1.43M 1.04%
10,069
-90
-0.9% -$13.3K
KHC icon
24
Kraft Heinz
KHC
$30.4B
$1.35M 0.98%
+36,627
New +$1.38M
FIXD icon
25
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
$1.26M 0.92%
23,560
-143
-0.6% -$7.72K

Similar funds

Chiron Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Chiron Capital Management held 103 positions worth $137M, up 14% from $120M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Chiron Capital Management deployed $25.1M of net new capital in Q3 2021, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Lockheed Martin: 4,310 shares worth $1.49M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 54% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Pfizer, an estimated $3.1M trimmed.

  • Chiron Capital Management's largest Q3 2021 buy was Lockheed Martin: 4,310 shares worth $1.49M.
  • Chiron Capital Management added most to State Street SPDR S&P Biotech ETF in Q3 2021, an estimated $3.99M increase.
  • Chiron Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.1M.
  • Chiron Capital Management fully exited Johnson & Johnson in Q3 2021, selling an estimated $214K.
  • Chiron Capital Management's ten largest holdings make up 53% of its $137M portfolio in Q3 2021.
  • Chiron Capital Management opened 24 new positions and closed 2 in Q3 2021.
  • Chiron Capital Management's portfolio value rose 14% quarter-over-quarter to $137M.

Based on Chiron Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.